Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Folic acid adjunctive therapy with sertraline in first-episode OCD
ChiCTR2200058311Phase 4Not yet recruiting
- Sponsor
- Xi'an Mental Health Center
- Start
- Apr 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of sertraline and folic acid in obsessive compulsive disorder (OCD) (2 arms), sponsored by Xi'an Mental Health Center. Primary endpoints: Yale-Brown Obsessive-Compulsive Symptom Scale (Y-BOCS) and Drug Side Effect Scale. Planned start Apr 2022; status: not yet recruiting.
02
Drugs
sertralinefolic acid
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on ChiCTR2200058311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200058311.